Monk BJ - Search Results

1

Efficacy and safety of tisotumab vedotin in previously treated recurrent or metastatic cervical cancer (innovaTV 204/GOG-3023/ENGOT-cx6): a multicentre, open-label, single-arm, phase 2 study.

Coleman RL, Lorusso D, Gennigens C, González-Martín A, Randall L, Cibula D, Lund B, Woelber L, Pignata S, Forget F, Redondo A, Vindeløv SD, Chen M, Harris JR, Smith M, Nicacio LV, Teng MSL, Laenen A, Rangwala R, Manso L, Mirza M, Monk BJ, Vergote I; innovaTV 204/GOG-3023/ENGOT-cx6 Collaborators. Coleman RL, et al. Among authors: monk bj. Lancet Oncol. 2021 May;22(5):609-619. doi: 10.1016/S1470-2045(21)00056-5. Epub 2021 Apr 9. Lancet Oncol. 2021. PMID: 33845034 Clinical Trial.

2

Intraperitoneal mitomycin C in the treatment of peritoneal carcinomatosis following second-look surgery.

Monk BJ, Surwit EA, Alberts DS, Graham V. Monk BJ, et al. Semin Oncol. 1988 Jun;15(3 Suppl 4):27-31. Semin Oncol. 1988. PMID: 3134695

3

Phase II trial of vinorelbine in recurrent and progressive epithelial ovarian cancer.

Burger RA, DiSaia PJ, Roberts JA, O'rourke M, Gershenson DM, Homesley HD, Lichtman SM, Barnes W, Moore DH, Monk BJ. Burger RA, et al. Among authors: monk bj. Gynecol Oncol. 1999 Feb;72(2):148-53. doi: 10.1006/gyno.1998.5243. Gynecol Oncol. 1999. PMID: 10021293 Clinical Trial.

4

Phase II study of cisplatin and vinorelbine in squamous cell carcinoma of the cervix: a gynecologic oncology group study.

Morris M, Blessing JA, Monk BJ, McGehee R, Moore DH. Morris M, et al. Among authors: monk bj. J Clin Oncol. 2004 Aug 15;22(16):3340-4. doi: 10.1200/JCO.2004.12.006. J Clin Oncol. 2004. PMID: 15310778 Clinical Trial.

5

Gynecologic oncology group trials of chemotherapy for metastatic and recurrent cervical cancer.

Tewari KS, Monk BJ. Tewari KS, et al. Among authors: monk bj. Curr Oncol Rep. 2005 Nov;7(6):419-34. doi: 10.1007/s11912-005-0007-z. Curr Oncol Rep. 2005. PMID: 16221379 Review.

6

Phase III trial of ifosfamide with or without paclitaxel in advanced uterine carcinosarcoma: a Gynecologic Oncology Group Study.

Homesley HD, Filiaci V, Markman M, Bitterman P, Eaton L, Kilgore LC, Monk BJ, Ueland FR; Gynecologic Oncology Group. Homesley HD, et al. Among authors: monk bj. J Clin Oncol. 2007 Feb 10;25(5):526-31. doi: 10.1200/JCO.2006.06.4907. J Clin Oncol. 2007. PMID: 17290061 Clinical Trial.

7

A feasibility study of topotecan with standard-dose cisplatin and concurrent primary radiation therapy in locally advanced cervical cancer.

Gatcliffe TA, Tewari KS, Shah A, Brewster WR, Burger RA, Kuo JV, Monk BJ. Gatcliffe TA, et al. Among authors: monk bj. Gynecol Oncol. 2009 Jan;112(1):85-9. doi: 10.1016/j.ygyno.2008.09.029. Epub 2008 Nov 1. Gynecol Oncol. 2009. PMID: 18977518 Clinical Trial.

8

Markers of angiogenesis in high-risk, early-stage cervical cancer: A Gynecologic Oncology Group study.

Randall LM, Monk BJ, Darcy KM, Tian C, Burger RA, Liao SY, Peters WA, Stock RJ, Fruehauf JP. Randall LM, et al. Among authors: monk bj. Gynecol Oncol. 2009 Mar;112(3):583-9. doi: 10.1016/j.ygyno.2008.11.013. Epub 2008 Dec 24. Gynecol Oncol. 2009. PMID: 19110305 Free PMC article. Clinical Trial.

9

Recent achievements and future developments in advanced and recurrent cervical cancer: trials of the Gynecologic Oncology Group.

Tewari KS, Monk BJ. Tewari KS, et al. Among authors: monk bj. Semin Oncol. 2009 Apr;36(2):170-80. doi: 10.1053/j.seminoncol.2008.12.008. Semin Oncol. 2009. PMID: 19332251 Review.

10

Anti-angiogenesis agents in metastatic or recurrent cervical cancer.

Monk BJ, Willmott LJ, Sumner DA. Monk BJ, et al. Gynecol Oncol. 2010 Feb;116(2):181-6. doi: 10.1016/j.ygyno.2009.09.033. Epub 2009 Oct 27. Gynecol Oncol. 2010. PMID: 19861227 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

438 results

Search Page